278 related articles for article (PubMed ID: 11254448)
1. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
2. HPC2/ELAC2 gene variants associated with incident prostate cancer.
Adler D; Kanji N; Trpkov K; Fick G; Hughes RM
J Hum Genet; 2003; 48(12):634-638. PubMed ID: 14625808
[TBL] [Abstract][Full Text] [Related]
3. Role of HPC2/ELAC2 in hereditary prostate cancer.
Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
[TBL] [Abstract][Full Text] [Related]
4. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.
Xu J; Zheng SL; Hawkins GA; Faith DA; Kelly B; Isaacs SD; Wiley KE; Chang B; Ewing CM; Bujnovszky P; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Aug; 69(2):341-50. PubMed ID: 11443539
[TBL] [Abstract][Full Text] [Related]
5. ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.
Xu B; Tong N; Li JM; Zhang ZD; Wu HF
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):270-7. PubMed ID: 20231859
[TBL] [Abstract][Full Text] [Related]
6. Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.
Stanford JL; Sabacan LP; Noonan EA; Iwasaki L; Shu J; Feng Z; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):876-81. PubMed ID: 14504198
[TBL] [Abstract][Full Text] [Related]
7. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
[TBL] [Abstract][Full Text] [Related]
8. Association of HPC2/ELAC2 genotypes and prostate cancer.
Rebbeck TR; Walker AH; Zeigler-Johnson C; Weisburg S; Martin AM; Nathanson KL; Wein AJ; Malkowicz SB
Am J Hum Genet; 2000 Oct; 67(4):1014-9. PubMed ID: 10986046
[TBL] [Abstract][Full Text] [Related]
9. Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.
Fujiwara H; Emi M; Nagai H; Nishimura T; Konishi N; Kubota Y; Ichikawa T; Takahashi S; Shuin T; Habuchi T; Ogawa O; Inoue K; Skolnick MH; Swensen J; Camp NJ; Tavtigian SV
J Hum Genet; 2002; 47(12):641-8. PubMed ID: 12522685
[TBL] [Abstract][Full Text] [Related]
10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
11. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.
Suarez BK; Gerhard DS; Lin J; Haberer B; Nguyen L; Kesterson NK; Catalona WJ
Cancer Res; 2001 Jul; 61(13):4982-4. PubMed ID: 11431329
[TBL] [Abstract][Full Text] [Related]
13. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
Severi G; Giles GG; Southey MC; Tesoriero A; Tilley W; Neufing P; Morris H; English DR; McCredie MR; Boyle P; Hopper JL
J Natl Cancer Inst; 2003 Jun; 95(11):818-24. PubMed ID: 12783937
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
[TBL] [Abstract][Full Text] [Related]
15. HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.
Meitz JC; Edwards SM; Easton DF; Murkin A; Ardern-Jones A; Jackson RA; Williams S; Dearnaley DP; Stratton MR; Houlston RS; Eeles RA;
Br J Cancer; 2002 Oct; 87(8):905-8. PubMed ID: 12373607
[TBL] [Abstract][Full Text] [Related]
16. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
[TBL] [Abstract][Full Text] [Related]
17. A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer.
Zahiri Z; Zahiri F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1551-1557. PubMed ID: 32592348
[TBL] [Abstract][Full Text] [Related]
18. HPC2 variants and screen-detected prostate cancer.
Vesprini D; Nam RK; Trachtenberg J; Jewett MA; Tavtigian SV; Emami M; Ho M; Toi A; Narod SA
Am J Hum Genet; 2001 Apr; 68(4):912-7. PubMed ID: 11254449
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.
Camp NJ; Tavtigian SV
Am J Hum Genet; 2002 Dec; 71(6):1475-8. PubMed ID: 12515253
[No Abstract] [Full Text] [Related]
20. Perspective: prostate cancer susceptibility genes.
Simard J; Dumont M; Soucy P; Labrie F
Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
